(R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol

We are (R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol CAS:716-61-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol
CAS.NO:716-61-0
Synonyms:(R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol
D-(-)-THREO-2-AMINO-1-(4-NITROPHENYL)-1,3-PROPANEDIOL
(1R,2R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol
2-Amino-1-(4-nitrophenyl)-1,3-propanediol
2-amino-1-(4-nitrophenyl)propane-1,3-diol
D-(-)-threo-2-Amino-1-(p-nitrophenyl)-1,3-propanediol
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 451.9±45.0 °C at 760 mmHg
Melting Point 163-165ºC
Molecular Formula C9H12N2O4
Molecular Weight 212.203
Flash Point 227.1±28.7 °C
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.630
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Chloramphenicol(CAS:56-75-7).

(R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol


Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.azetidin-3-ona, hidrocloruro CAS:17557-84-5 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.5-bromo-2-fluoro-3-metilpiridina CAS:29312-98-9 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.822-17-3 China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.

Related Products
Product Name
Tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione View Details
H-HIS-GLY-GLY-OH View Details
Fmoc-L-alaninol View Details
Tetramethylammonium Sulfate Cas:14190-16-0 manufacturer 2,2,3,3-Tetrafluoropropyl Acrylate Cas:7383-71-3 manufacturer 4-nitroheptanedial manufacturer 2′-Amino-5′-chloro-2,2,2-trifluoroacetophenone manufacturer diethyl 2-(thiophen-2-ylmethylidene)propanedioate manufacturer